Q2 2024 · —
Revenue$1.95M$1.95M no prior Q2 2023 on file+60.2% vs Q1 2024
Net Income-$6.92M-$6.92M no prior Q2 2023 on fileN/M vs Q1 2024
EPS Diluted$0.28$0.28 no prior Q2 2023 on file+3.7% vs Q1 2024
Gross Profit$1,421,000—
Operating Income-$7,842,000—
Operating Cash Flowderived-$6,219,000—
Margins · derived
Gross margin72.8%
Operating margin-401.5%
Net margin-354.3%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q2 2023 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Profound Medical Corp. · CIK 1628808 · Engraved from SEC EDGAR